332 related articles for article (PubMed ID: 18035187)
1. Ranibizumab for the treatment of neovascular age-related macular degeneration: a review.
Kourlas H; Abrams P
Clin Ther; 2007 Sep; 29(9):1850-61. PubMed ID: 18035187
[TBL] [Abstract][Full Text] [Related]
2. Anti-vascular endothelial growth factor for neovascular age-related macular degeneration.
Solomon SD; Lindsley K; Vedula SS; Krzystolik MG; Hawkins BS
Cochrane Database Syst Rev; 2014 Aug; 8(8):CD005139. PubMed ID: 25170575
[TBL] [Abstract][Full Text] [Related]
3. Anti-vascular endothelial growth factor for choroidal neovascularisation in people with pathological myopia.
Zhu Y; Zhang T; Xu G; Peng L
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD011160. PubMed ID: 27977064
[TBL] [Abstract][Full Text] [Related]
4. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration.
Vedula SS; Krzystolik MG
Cochrane Database Syst Rev; 2008 Apr; (2):CD005139. PubMed ID: 18425911
[TBL] [Abstract][Full Text] [Related]
5. Anti-vascular endothelial growth factor biosimilars for neovascular age-related macular degeneration.
Sunaga T; Maeda M; Saulle R; Ng SM; Sato MT; Hasegawa T; Mason AN; Noma H; Ota E
Cochrane Database Syst Rev; 2024 Jun; 6(6):CD015804. PubMed ID: 38829176
[TBL] [Abstract][Full Text] [Related]
6. Higher irradiance and photodynamic therapy for age-related macular degeneration (an AOS thesis).
Miller JW
Trans Am Ophthalmol Soc; 2008; 106():357-82. PubMed ID: 19277246
[TBL] [Abstract][Full Text] [Related]
7. The goal of value-based medicine analyses: comparability. The case for neovascular macular degeneration.
Brown GC; Brown MM; Brown HC; Kindermann S; Sharma S
Trans Am Ophthalmol Soc; 2007; 105():160-9; discussion 169-71. PubMed ID: 18427606
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy with verteporfin is effective, but how big is its effect? Results of a systematic review.
Meads C; Hyde C
Br J Ophthalmol; 2004 Feb; 88(2):212-7. PubMed ID: 14736777
[TBL] [Abstract][Full Text] [Related]
9. Age-related macular degeneration.
Coleman HR; Chan CC; Ferris FL; Chew EY
Lancet; 2008 Nov; 372(9652):1835-45. PubMed ID: 19027484
[TBL] [Abstract][Full Text] [Related]
10. JP1, a polypeptide specifically targeting integrin αVβ3, ameliorates choroidal neovascularization and diabetic retinopathy in mice.
Xie Z; Wu XJ; Cheng RW; Cui JH; Yuan ST; Zhou JW; Liu QH
Acta Pharmacol Sin; 2023 Apr; 44(4):897-912. PubMed ID: 36280689
[TBL] [Abstract][Full Text] [Related]
11. Verteporfin Photodynamic Therapy for the Treatment of Chorioretinal Conditions: A Narrative Review.
Garg SJ; Hadziahmetovic M
Clin Ophthalmol; 2024; 18():1701-1716. PubMed ID: 38881707
[TBL] [Abstract][Full Text] [Related]
12. Treatment Strategies for Anti-VEGF Resistance in Neovascular Age-Related Macular Degeneration by Targeting Arteriolar Choroidal Neovascularization.
Fu Y; Zhang Z; Webster KA; Paulus YM
Biomolecules; 2024 Feb; 14(3):. PubMed ID: 38540673
[TBL] [Abstract][Full Text] [Related]
13. The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trial.
Joussen AM; Wolf S; Kaiser PK; Boyer D; Schmelter T; Sandbrink R; Zeitz O; Deeg G; Richter A; Zimmermann T; Hoechel J; Buetehorn U; Schmitt W; Stemper B; Boettger MK
Br J Clin Pharmacol; 2019 Feb; 85(2):347-355. PubMed ID: 30341774
[TBL] [Abstract][Full Text] [Related]
14. Age related macular degeneration.
Arnold JJ; Heriot W
BMJ Clin Evid; 2007 Apr; 2007():. PubMed ID: 19454069
[TBL] [Abstract][Full Text] [Related]
15. Applications of nanomaterials in anti-VEGF treatment for ophthalmic diseases.
Teng L; Sun Y; Teng S; Hui P
J Biomed Mater Res A; 2024 Feb; 112(2):296-306. PubMed ID: 37850566
[TBL] [Abstract][Full Text] [Related]
16. Efficacy, Safety and Immunogenicity of Sun's Ranibizumab Biosimilar in Neovascular Age-Related Macular Degeneration: A Phase 3, Double-Blind Comparative Study.
Ghosh AK; Nikumbh US; Shukla CK; Laul RS; Dixit A; Mahapatra SK; Nayak S; Shah UM; Parwal S; Venkatapathy N; Radhakrishnan N; Kelgaonkar A; Saxena S; Mishra D; Dave VP; Khan P; Saswade MR; Shantilal MS; Ramasamy K; Sreekanta S; Rajurkar M; Doshi M; Behera S; Patel P; Dhawan S; Lakhwani L
Ophthalmol Ther; 2024 May; 13(5):1369-1382. PubMed ID: 38530568
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of diode laser photodynamic therapy with ICG dye in ARMD: a case report.
Yoon CK; Kyoung SE; Chang MH
Korean J Ophthalmol; 2007 Mar; 21(1):55-60. PubMed ID: 17460435
[TBL] [Abstract][Full Text] [Related]
18. Bilateral neovascular age-related macular degeneration: unilateral regression following endophthalmitis with persistent activity in the fellow eye.
Gaur S; Singh DV; Reddy RR; Sharma A
BMJ Case Rep; 2022 Mar; 15(3):. PubMed ID: 35332000
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and treatment patterns of ranibizumab and photodynamic therapy in a tertiary care setting in Malaysia.
Mohamad NA; Ramachandran V; Ismail P; Mohd Isa H; Chan YM; Ngah NF; Md Bakri N; Ching SM; Hoo FK; Wan Sulaiman WA
Int J Ophthalmol; 2017; 10(12):1889-1897. PubMed ID: 29259909
[TBL] [Abstract][Full Text] [Related]
20. Intraocular inflammation as a major adverse event of anti-vascular endothelial growth factor therapy for neovascular age-related macular degeneration: from clinical trials to real-world practice.
Kim JH
Expert Opin Drug Saf; 2024 Jun; 23(6):659-661. PubMed ID: 38696228
[No Abstract] [Full Text] [Related]
[Next] [New Search]
